Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19.
Biomark Med
; 14(10): 827-837, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-506060
ABSTRACT
Aim:
We aimed to explore the biomarkers for disease progression or the risk of nonsurvivors. Materials &methods:
This study included 134 hospitalized patients with confirmed COVID-19 infection. The outcome of moderate versus severe versus critically ill patients and survivors versus nonsurvivors were compared.Results:
An increase in the severity of COVID-19 pneumonia was positively associated with lower levels of platelets and albumin (all p < 0.05). In the critical group, the plasma levels of albumin continued to have a significant association for the risk of nonsurvivors (p < 0.05), even after adjusting for confounding factors.Conclusion:
Albumin levels could be used as an independent predictor of the risk of nonsurvivors in critically ill patients with COVID-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Serum Albumin
/
Critical Illness
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Biomark Med
Journal subject:
Biochemistry
/
Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Bmm-2020-0254
Similar
MEDLINE
...
LILACS
LIS